The HOXA6 antibody is a tool used to detect and study the HOXA6 protein, a member of the homeobox (HOX) gene family. HOX genes encode transcription factors critical for embryonic development, particularly in establishing body axis patterning and organogenesis. HOXA6. located on chromosome 7p15.2. plays roles in hematopoietic, skeletal, and reproductive system development. Dysregulation of HOXA6 has been linked to cancers, including leukemia, colorectal cancer, and lung adenocarcinoma, where it may act as an oncogene or tumor suppressor depending on context.
HOXA6 antibodies are typically monoclonal or polyclonal, generated in hosts like rabbits or mice, and validated for applications such as Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and flow cytometry. These antibodies help researchers analyze HOXA6 expression patterns, subcellular localization (primarily nuclear), and interactions with regulatory proteins.
Studies using HOXA6 antibodies have revealed its involvement in cell differentiation, proliferation, and apoptosis. For instance, reduced HOXA6 expression correlates with poor prognosis in certain cancers, suggesting its potential as a biomarker. Additionally, HOXA6 interacts with signaling pathways like Wnt and TGF-β, offering insights into therapeutic targets. The antibody remains vital for exploring HOXA6's dual roles in development and disease.